Has Issued 5,000,000 Shares of Series A Preferred Stock

About Predictive Therapeutics

Predictive Therapeutics is a clinical stage oncology company, with a focus on immunotherapy. We seek to acquire undervalued late stage assets for clinical development. Our goal is to unlock the potential of these promising cancer therapies in order to bring effective and safe drugs to patients.

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • New York

    555 Fifth Ave.
    19th Floor
    New York, NY 10017
    (212) 350-8213

  • Boston

    99 High St.
    Suite 2900
    Boston, MA 02110
    (617) 431-4886

  • Washington DC

    11921 Freedom Dr.
    Suite 730
    Reston, VA 20190
    (617) 431-4886